Uromedica
Manufacturing · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1840 Berkshire Ln N, Plymouth, Minnesota...Phone Number
(763) 694-9880Website
www.uromedica-inc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Uromedica
Uromedica, Inc. is a privately held, Minnesota-based medical device company that has developed and manufactures a long-term implantable balloon therapy for the treatment of stress urinary incontinence in men and women. ProACT has been implanted in over 11,000 patients worldwide since 1997.Explore more
Uromedica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Uromedica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Uromedica, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Uromedica had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Uromedica
Check if Uromedica has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Uromedica has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Uromedica recently announced quarterly report
Check out if Uromedica is spiking on competitors!
Product Launch: Get notified when Uromedica launches new products
Recommended Actions
Reach out to Masked Content who joined Uromedica as Masked Content
Find 2 more new buyers
Compare Similar Companies to Uromedica
Compare insights from companies similar to Uromedica, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Uromedica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Uromedica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Uromedica.
Uromedica financials insights
Gather financial insights about Uromedica, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$228K
Uromedica Tech Stack
A closer look at the technologies used by Uromedica
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Funding
Uromedica has received an SBA PPP loan in the amount of $227,320 from U.S. Bank resulting in the retention of 13 jobs.
Funding
Uromedica has received an SBA PPP loan for $150,000-350,000 from U.S. Bank, supporting the retention of 12 jobs.
Funding
Uromedica News & Media
Uromedica Announces New CPT-I codes for ProACT™ Adjustable Continence Therapy for Men
MINNEAPOLIS--(BUSINESS WIRE)-- #ProACTTherapy--Uromedica, Inc. announces today that four new Category I CPT (Current Procedural Terminology) codes have been assigned to their FDA-approved product, ProACT™ Adjustable Continence Therapy for Men and will be effective January 1st, 2022. The new CPT-I codes will be: 53451 (bilateral insertion), 53452 (unilateral insertion), 53453 (removal), and 53454 (percutaneous adjustment of balloon(s) fluid volume). The ProACT Therapy previously received CategoryFirst Patients Enrolled in Uromedica’s Adjustable Continence Therapy (ACT®) for Female Stress Urinary Incontinence (SUI) Trial
MINNEAPOLIS--(BUSINESS WIRE)--Uromedica, Inc. announces the initiation of its FDA IDE trial for ACT to evaluate its safety and efficacy for treatment of female SUI.UROMEDICA Announces Successful First US Commercial Implant of ProACT™ Adjustable Continence Therapy for Men
PLYMOUTH, Minn.--(BUSINESS WIRE)--The first US commercial implant of Uromedica's FDA approved device, ProACT™ Adjustable Continence Therapy for Men, has been completed successfully.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Uromedica
Sign Up For FreeTo access detailed company insights
Uromedica, Inc. is a privately held, Minnesota-based medical device company that has developed and manufactures a long-term implantable balloon therapy for the treatment of stress urinary incontinence in men and women. ProACT has been implanted in over 11,000 patients worldwide since 1997.... Read More
